Laddar...
Study Design Considerations for Evaluating Efficacy of Systemic Pre-Exposure Prophylaxis Interventions
BACKGROUND: The development of interventions for systemic Pre-Exposure Prophylaxis (PrEP) faces several significant challenges following the US Food and Drug Administration’s (FDA) approval of Emtricitabine/Tenofovir (FTC/TDF) for HIV prevention. This development is particularly complex because of i...
Sparad:
| Huvudupphovsmän: | , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3725298/ https://ncbi.nlm.nih.gov/pubmed/23764624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e3182986fac |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|